FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2942239563> ?p ?o ?g. }

• W2942239563 endingPage "249" @default.
• W2942239563 startingPage "239" @default.
• W2942239563 abstract "Currently, direct comparative safety between endothelin receptor antagonists (ERAs) in pulmonary arterial hypertension (PAH) is limited. Thus, a systematic review with network analysis was conducted.An electronic search was performed for randomized controlled trials (RCTs) that reported the interested safety data (abnormal liver function, peripheral edema, and anemia) of ERAs in PAH. Risk ratios (RRs) with their confidence intervals (CIs) and the surface under the cumulative ranking curve (SUCRA) were calculated using a network analysis.Ten RCTs involving 2,288 patients were included. Compared with placebo, bosentan (RR, 2.93; 95% CI, 1.78-4.84) significantly increased the risk of abnormal liver function, ambrisentan (RR, 1.62; 95% CI, 1.23-2.13) significantly increased the risk of peripheral edema, and macitentan (RR, 3.42; 95% CI, 1.65-7.07) significantly increased the risk of anemia. SUCRA analysis suggested that bosentan 125 mg twice daily had the highest risk of abnormal liver function; ambrisentan 10 mg once daily had the highest risk of peripheral edema; macitentan 10 mg once daily had the highest risk of anemia.Abnormal liver function (bosentan), peripheral edema (ambrisentan), and anemia (macitentan) were the safety indicators of ERAs in patients with PAH. Different monitoring parameters should be considered for individual ERA." @default.
• W2942239563 created "2019-05-03" @default.
• W2942239563 creator A5008247363 @default.
• W2942239563 creator A5012852128 @default.
• W2942239563 creator A5031268002 @default.
• W2942239563 creator A5049520168 @default.
• W2942239563 creator A5062154647 @default.
• W2942239563 creator A5062429074 @default.
• W2942239563 creator A5073545179 @default.
• W2942239563 creator A5081207814 @default.
• W2942239563 creator A5090728786 @default.
• W2942239563 date "2019-06-01" @default.
• W2942239563 modified "2023-10-16" @default.
• W2942239563 title "A network meta-analysis for safety of endothelin receptor antagonists in pulmonary arterial hypertension" @default.
• W2942239563 cites W1617328014 @default.
• W2942239563 cites W1974227996 @default.
• W2942239563 cites W1980311339 @default.
• W2942239563 cites W1986013929 @default.
• W2942239563 cites W1994680391 @default.
• W2942239563 cites W2033440519 @default.
• W2942239563 cites W2039662407 @default.
• W2942239563 cites W2048443661 @default.
• W2942239563 cites W2048732558 @default.
• W2942239563 cites W2051069436 @default.
• W2942239563 cites W2073730215 @default.
• W2942239563 cites W2098923148 @default.
• W2942239563 cites W2101437558 @default.
• W2942239563 cites W2108267868 @default.
• W2942239563 cites W2110637500 @default.
• W2942239563 cites W2112229901 @default.
• W2942239563 cites W2121538692 @default.
• W2942239563 cites W2124586765 @default.
• W2942239563 cites W2125435699 @default.
• W2942239563 cites W2130961266 @default.
• W2942239563 cites W2137907407 @default.
• W2942239563 cites W2138649273 @default.
• W2942239563 cites W2140168661 @default.
• W2942239563 cites W2143132974 @default.
• W2942239563 cites W2146193242 @default.
• W2942239563 cites W2152357527 @default.
• W2942239563 cites W2157947374 @default.
• W2942239563 cites W2158862125 @default.
• W2942239563 cites W2288033263 @default.
• W2942239563 cites W2499464580 @default.
• W2942239563 cites W2540776065 @default.
• W2942239563 cites W2588681363 @default.
• W2942239563 cites W2794675646 @default.
• W2942239563 cites W2803360066 @default.
• W2942239563 doi "https://doi.org/10.21037/cdt.2019.03.02" @default.
• W2942239563 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6603502" @default.
• W2942239563 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31275814" @default.
• W2942239563 hasPublicationYear "2019" @default.
• W2942239563 type Work @default.
• W2942239563 sameAs 2942239563 @default.
• W2942239563 citedByCount "9" @default.
• W2942239563 countsByYear W29422395632020 @default.
• W2942239563 countsByYear W29422395632021 @default.
• W2942239563 countsByYear W29422395632022 @default.
• W2942239563 countsByYear W29422395632023 @default.
• W2942239563 crossrefType "journal-article" @default.
• W2942239563 hasAuthorship W2942239563A5008247363 @default.
• W2942239563 hasAuthorship W2942239563A5012852128 @default.
• W2942239563 hasAuthorship W2942239563A5031268002 @default.
• W2942239563 hasAuthorship W2942239563A5049520168 @default.
• W2942239563 hasAuthorship W2942239563A5062154647 @default.
• W2942239563 hasAuthorship W2942239563A5062429074 @default.
• W2942239563 hasAuthorship W2942239563A5073545179 @default.
• W2942239563 hasAuthorship W2942239563A5081207814 @default.
• W2942239563 hasAuthorship W2942239563A5090728786 @default.
• W2942239563 hasBestOaLocation W29422395631 @default.
• W2942239563 hasConcept C126322002 @default.
• W2942239563 hasConcept C142724271 @default.
• W2942239563 hasConcept C144980905 @default.
• W2942239563 hasConcept C164705383 @default.
• W2942239563 hasConcept C170493617 @default.
• W2942239563 hasConcept C197934379 @default.
• W2942239563 hasConcept C204787440 @default.
• W2942239563 hasConcept C27081682 @default.
• W2942239563 hasConcept C2777482430 @default.
• W2942239563 hasConcept C2780263000 @default.
• W2942239563 hasConcept C2781109936 @default.
• W2942239563 hasConcept C2992208098 @default.
• W2942239563 hasConcept C71924100 @default.
• W2942239563 hasConcept C90924648 @default.
• W2942239563 hasConcept C95190672 @default.
• W2942239563 hasConceptScore W2942239563C126322002 @default.
• W2942239563 hasConceptScore W2942239563C142724271 @default.
• W2942239563 hasConceptScore W2942239563C144980905 @default.
• W2942239563 hasConceptScore W2942239563C164705383 @default.
• W2942239563 hasConceptScore W2942239563C170493617 @default.
• W2942239563 hasConceptScore W2942239563C197934379 @default.
• W2942239563 hasConceptScore W2942239563C204787440 @default.
• W2942239563 hasConceptScore W2942239563C27081682 @default.
• W2942239563 hasConceptScore W2942239563C2777482430 @default.
• W2942239563 hasConceptScore W2942239563C2780263000 @default.
• W2942239563 hasConceptScore W2942239563C2781109936 @default.
• W2942239563 hasConceptScore W2942239563C2992208098 @default.
• W2942239563 hasConceptScore W2942239563C71924100 @default.

• next